BRN (ASX) 2021 BRN Discussion

Originally posted by Pharvest: ↑

OK I'm going to weigh in on this Nanose device. Please don't read this as a BRN down ramp as I have put a considerable amount on BRN after learning of the Renesas deal and NASA, Ford etc trialling the technology and I hope it goes to the moon someday soon as much as anyone who is invested.

Having had a quick poke around looking into the literature available on the Nanose, I cannot find anything that gives guidance on at what stage of infection this device is able to detect Covid19? This is incredibly important if this device is to be considered useful as a screening device.

Don't get me wrong I think the fact that Akida can be used in this device to pick up covid, cancers and any other deadly condition is incredible I just think from reading the threads there appears to be a few who can't understand why the Nanose announcement hasn't put a rocket under the share price. I'm just here to point out that when it comes to Covid 19 testing there are a lot of things to consider. For instance, is this device detecting the antibodies an infected person's body produces to fight the infection or the antigen ( virus ) itself? This makes a huge difference if a device is to be used to stop the spread. A person may be asymptomatic ( and infectious ) for up to three weeks before developing antibodies to the disease, if it is covid antibodies the device is detecting I wouldn't be holding out a great amount of hope for Nanose becoming a global sensation in Covid screening. Does anyone have more information on the sensitivity and specificity of the test? It's easy to say we can detect Covid but there are a plethora of rapid antigen and antibody tests on the market that can do that in 15 mins already, for me this device is going to have to be extremely accurate to warrant too much excitement about it, and I can't find any info available as yet that leads me to believe this will be the case. The data may come back soon that it is the most accurate test available but until we have said data available the jury is most definitely out.

I have developed a pretty good knowledge base on Covid19 Tests and testing through being invested in Brisbane based Anteotech ( ADO ). Their anteobind technology underpins the Ellume home tests that have made headlines recently with the US department of defence throwing nearly 300 million behind them including building a new factory in Maryland to manufacture their test. Anteotech are about to launch their own antigen rapid test at the end of this quarter once they have the results of the clinical trial that is being conducted by the Victorian infectious diseases reference laboratory a department of the world renowned Dougherty Institute. Anteotech are already very confident our results will mirror our own findings in that our lower limit of detection ( LLOD ) is very very low, in fact this is somewhat already validated in that it is the Anteobind in the Ellume tests that makes them so accurate. It is said to be almost on par with the polyrase chain reaction ( PCR ) tests that are performed in the labs- and are the only test allowed by the Australian government at this stage. So again this test detects the infinitesimally small virus itself within days of infection and can actually detect it before a carrier has themselves become infectious.. this is a huge point. The company has also engaged Novotech to conduct a further trial in India on live patients using both the nasal swab sample and a saliva sample. They believe their tech is that accurate that they will be able to offer a highly accurate test utilising saliva samples alone which will be a big game changer... anyone who has had a Covid test in the last year I'm sure will understand why I say this.. My eyes are still watering from the last 'brain probe' I experienced at Christmas time. The company have manufacturing in Europe ready to begin by Operon of Spain and will also be manufacturing and exporting from Australia they have also stated stating they are seeking manufacturing partners in Asia and the US.

I still believe that a device such as Nanose is an incredible leap forward and bloody amazing quite frankly. To think that you may be able to just one day give a quick blow into it at your GP's office while having a check up and be instantly screened for several different types of deadly cancers etc, that is an amazing thing to be a small part of by way of your investment in BRN. I just think that some may need to temper their expectations on an exploding SP brought on by massive uptake of this device in the fight against Covid, there is still a lot more hard data that needs to come out on how effective it will be.

Regardless of Nanose the shares of BRN are extremely undervalued at the moment just based on everything else they've got going on in my opinion.

GLTA, Pharvest

Expand

it didn't put a rocket under the share price because
A) all of us already knew about it
B) nanose had already done a huge round of press in August last year, eg .

https://www.israel21c.org/breathalyzer-from-israel-a-gamechanger-for-covid-testing/

New breath test sniffs out Covid-19 in 30 seconds

the next set of clinical studies should provide more answers

No.	Vol.	Price($)
47	1538105	18.5¢

No.

Vol.

Price($)

1538105

18.5¢

Price($)	Vol.	No.
19.0¢	258902	14

Price($)

Vol.

No.

19.0¢

258902

No.	Vol.	Price($)
31	548123	0.190
40	1559092	0.185
48	1466110	0.180
18	407183	0.175
27	616734	0.170

No.

Vol.

Price($)

548123

0.190

1559092

0.185

1466110

0.180

407183

0.175

616734

0.170

Price($)	Vol.	No.
0.195	451643	23
0.200	711443	22
0.205	401466	7
0.210	277142	4
0.215	240411	5

Price($)

Vol.

No.

0.195

451643

0.200

711443

0.205

401466

0.210

277142

0.215

240411

(20min delay)
Last 18.8¢		Change -0.013(6.25%)		Mkt cap ! $361.9M

Open	High	Low	Value	Volume
19.0¢	19.5¢	18.5¢	$968.4K	5.095M

2021 BRN Discussion, page-578

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Geochemical work at Newington picks up gold and copper anomalies for Midas

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

2021 BRN Discussion, page-578

Top Stories

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Geochemical work at Newington picks up gold and copper anomalies for Midas

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News